{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:51:25Z","timestamp":1782215485609,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44634-x","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:17:12Z","timestamp":1777285032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human Tamm-Horsfall protein as a novel antitumor therapy for triple negative breast cancer and other solid tumors"],"prefix":"10.1038","volume":"16","author":[{"given":"Mar\u00eda Florencia","family":"Mercogliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Balanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Groisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Inserra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Schillaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M. V.","family":"de Cavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"2","key":"44634_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1042\/cs0440163","volume":"44","author":"AM Grant","year":"1973","unstructured":"Grant, A. M. & Neuberger, A. The development of a radioimmunoassay for the measurement of urinary Tamm-Horsfall glycoprotein in the presence of sodium dodecyl sulphate. Clin. Sci. 44(2), 163\u2013179 (1973).","journal-title":"Clin. Sci."},{"issue":"4","key":"44634_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0272-6386(03)00829-1","volume":"42","author":"F Serafini-Cessi","year":"2003","unstructured":"Serafini-Cessi, F., Malagolini, N. & Cavallone, D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am. J. Kidney Dis. 42(4), 658\u2013676 (2003).","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"44634_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1042\/cs0680529","volume":"68","author":"C Thornley","year":"1985","unstructured":"Thornley, C., Dawnay, A. & Cattell, W. R. Human Tamm-Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay. Clin. Sci. 68(5), 529\u2013535 (1985).","journal-title":"Clin. Sci."},{"issue":"4329","key":"44634_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/170662a0","volume":"1170","author":"A Gottschalk","year":"1952","unstructured":"Gottschalk, A. Carbohydrate residue of a urine mucoprotein inhibiting influenza virus haemagglutination. Nature 1170(4329), 662\u2013663 (1952).","journal-title":"Nature"},{"issue":"2","key":"44634_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1091\/mbc.e08-08-0876","volume":"20","author":"C Schaeffer","year":"2009","unstructured":"Schaeffer, C., Santambrogio, S., Perucca, S., Casari, G. & Rampoldi, L. Analysis of Uromodulin polymerization provides new insights into the mechanisms regulating ZP domain-mediated protein assembly. Mol. Biol. Cell 20(2), 589\u2013599 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"44634_CR6","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08887","volume":"4","author":"M Brunati","year":"2015","unstructured":"Brunati, M. et al. The serine protease hepsin mediates urinary secretion and polymerisation of zona pellucida domain protein uromodulin. Elife 4, e08887. https:\/\/doi.org\/10.7554\/eLife.08887 (2015).","journal-title":"Elife"},{"issue":"13","key":"44634_CR7","doi-asserted-by":"publisher","first-page":"9924","DOI":"10.1074\/jbc.M008610200","volume":"276","author":"J Pak","year":"2001","unstructured":"Pak, J., Pu, Y., Zhang, Z. T., Hasty, D. L. & Wu, X. R. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J. Biol. Chem. 276(13), 9924\u20139930 (2001).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"44634_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1462-5822.2002.00193.x","volume":"4","author":"MA Mulvey","year":"2002","unstructured":"Mulvey, M. A. Adhesion and entry of uropathogenic Escherichia coli. Cell. Microbiol. 4(5), 257\u2013271 (2002).","journal-title":"Cell. Microbiol."},{"key":"44634_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/B978-0-323-44942-7.00082-0","volume-title":"Critical Care Nephrology","author":"SM Opal","year":"2019","unstructured":"Opal, S. M. Innate immunity and the kidney. In Critical Care Nephrology Third ed. 476-482.e2 (Elsevier, 2019).","edition":"Third ed."},{"issue":"3","key":"44634_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1681\/ASN.2017040409","volume":"29","author":"R Micanovic","year":"2018","unstructured":"Micanovic, R. et al. Tamm-Horsfall protein regulates mononuclear phagocytes in the kidney. J. Am. Soc. Nephrol. 29(3), 841\u2013856 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"44634_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1172\/JCI200522720","volume":"115","author":"MD Saemann","year":"2005","unstructured":"Saemann, M. D. et al. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J. Clin. Invest. 115(2), 468\u2013475 (2005).","journal-title":"J. Clin. Invest."},{"issue":"9","key":"44634_CR12","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1681\/ASN.2014070664","volume":"26","author":"R Micanovic","year":"2015","unstructured":"Micanovic, R. et al. Tamm-Horsfall protein regulates granulopoiesis and systemic neutrophil homeostasis. J. Am. Soc. Nephrol. 26(9), 2172\u20132182 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"20","key":"44634_CR13","doi-asserted-by":"publisher","first-page":"16365","DOI":"10.1074\/jbc.M112.348243","volume":"287","author":"Y Liu","year":"2012","unstructured":"Liu, Y., El-Achkar, T. M. & Wu, X. R. Tamm-Horsfall protein regulates circulating and renal cytokines by affecting glomerular filtration rate and acting as a urinary cytokine trap. J. Biol. Chem. 287(20), 16365\u201316378 (2012).","journal-title":"J. Biol. Chem."},{"issue":"7","key":"44634_CR14","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho, A. M. et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int. J. Cancer. 156(7), 1336\u20131346 (2025).","journal-title":"Int. J. Cancer."},{"issue":"15 Pt 1","key":"44634_CR15","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent, R. et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 13(15 Pt 1), 4429\u20134434 (2007).","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"44634_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","volume":"293","author":"P Kumar","year":"2016","unstructured":"Kumar, P. & Aggarwal, R. An overview of triple-negative breast cancer. Arch. Gynecol. Obstet. 293(2), 247\u2013269 (2016).","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"44634_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami, P. & Carey, L. A. Triple negative breast cancer: Pitfalls and progress. Npj Breast Cancer 8(1), 95. https:\/\/doi.org\/10.1038\/s41523-022-00468-0 (2022).","journal-title":"Npj Breast Cancer"},{"issue":"2","key":"44634_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-008-0086-2","volume":"115","author":"R Dent","year":"2009","unstructured":"Dent, R. et al. Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res. Treat. 115(2), 423\u2013428 (2009).","journal-title":"Breast Cancer Res. Treat."},{"issue":"6797","key":"44634_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406(6797), 747\u2013752 (2000).","journal-title":"Nature"},{"key":"44634_CR20","doi-asserted-by":"crossref","unstructured":"Cortes, J., et al. 355 Investigators. Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. N Engl. J. Med. 387(3):217-226 (2022).","DOI":"10.1056\/NEJMoa2202809"},{"key":"44634_CR21","doi-asserted-by":"crossref","unstructured":"Schmid, P., et al. 522 Investigators. Pembrolizumab for early triple-negative breast cancer. N Engl. J. Med. 382(9); 810-821 (2020).","DOI":"10.1056\/NEJMoa1910549"},{"key":"44634_CR22","unstructured":"Cortes, J., et al. 355 Investigators. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer: A randomised, placebo-controlled, double-blind, phase 3 clinical trial. Lancet. 396(10265): 1817\u20131828 (2020)."},{"key":"44634_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071674","volume":"381","author":"RA Leon-Ferre","year":"2023","unstructured":"Leon-Ferre, R. A. & Goetz, M. P. Advances in systemic therapies for triple negative breast cancer. BMJ 381, e071674. https:\/\/doi.org\/10.1136\/bmj-2022-071674 (2023).","journal-title":"BMJ"},{"issue":"2","key":"44634_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0022-1759(89)90241-X","volume":"120","author":"F Serafini-Cessi","year":"1989","unstructured":"Serafini-Cessi, F., Bellabarba, G., Malagolini, N. & Dall\u2019Olio, F. Rapid isolation of Tamm-Horsfall glycoprotein (uromodulin) from human urine. J. Immunol. Methods. 120(2), 185\u2013189 (1989).","journal-title":"J. Immunol. Methods."},{"issue":"1","key":"44634_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1006\/abbi.2000.2265","volume":"388","author":"K Kobayashi","year":"2001","unstructured":"Kobayashi, K. & Fukuoka, S. Conditions for solubilization of Tamm-Horsfall protein\/uromodulin in human urine and establishment of a sensitive and accurate enzyme-linked immunosorbent assay (ELISA) method. Arch. Biochem. Biophys. 388(1), 113\u2013120 (2001).","journal-title":"Arch. Biochem. Biophys."},{"key":"44634_CR26","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"Institute for Laboratory Animal Research","year":"2011","unstructured":"Institute for Laboratory Animal Research, National Research Council. Guide for the Care and Use of Laboratory Animals 8th Ed. (The National Academies Press, 2011).","edition":"8th Ed"},{"issue":"7","key":"44634_CR27","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.4049\/jimmunol.158.7.3449","volume":"158","author":"SJ Su","year":"1997","unstructured":"Su, S. J., Chang, K. L., Lin, T. M., Huang, Y. H. & Yeh, T. M. Uromodulin and Tamm-Horsfall protein induce human monocytes to secrete TNF and express tissue factor. J. Immunol. 158(7), 3449\u20133456 (1997).","journal-title":"J. Immunol."},{"issue":"3","key":"44634_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0162-3109(93)90041-N","volume":"26","author":"CL Yu","year":"1993","unstructured":"Yu, C. L. et al. Tamm-Horsfall urinary glycoprotein enhances monokine release and augments lymphocyte proliferation. Immunopharmacology 26(3), 249\u2013258 (1993).","journal-title":"Immunopharmacology"},{"key":"44634_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1007579","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. The development and improvement of immunodeficient mice and humanized immune system mouse models. Front. Immunol. 13, 1007579. https:\/\/doi.org\/10.3389\/fimmu.2022.1007579 (2022).","journal-title":"Front. Immunol."},{"issue":"4","key":"44634_CR30","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e27","volume":"18","author":"JS Roh","year":"2018","unstructured":"Roh, J. S. & Sohn, D. H. Damage-associated molecular patterns in inflammatory diseases.. Immune Netw. 18(4), e27. https:\/\/doi.org\/10.4110\/in.2018.18.e27 (2018).","journal-title":"Immune Netw."},{"issue":"4","key":"44634_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0045-6039(84)90016-2","volume":"14","author":"GP Bagnara","year":"1984","unstructured":"Bagnara, G. P., Valvassori, L., Marini, M., Franceschi, C. & Serafini-Cessi, F. Megakaryocytopoiesis in bone marrow-derived stromal-hemopoietic cells co-cultures: action of Tamm-Horsfall glycoprotein. Cell Differ. 14(4), 277\u2013285 (1984).","journal-title":"Cell Differ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44634-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:16:24Z","timestamp":1782213384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44634-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44634"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44634-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19411"}}